HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Validation study of the combined repeated-dose toxicity and genotoxicity assay using gpt delta rats.

Abstract
Transgenic rodents carrying reporter genes to detect organ-specific in vivo genetic alterations are useful for risk assessment of genotoxicity that causes cancer. Thus, the Organization for Economic Co-operation and Development has established the guideline for genotoxicity tests using transgenic animals, which may be combined with repeated-dose toxicity studies. Here, we provide evidence to support equivalence of gpt delta and wild type (WT) rats in terms of toxicological responses to a genotoxic hepatocarcinogen, N-nitrosodiethylamine (DEN), and a non-genotoxic hepatocarcinogen, di(2-ethylhexyl)phthalate (DEHP). gpt delta rats treated with DEHP showed similar increases in liver and kidney weights, serum albumin, albumin/globulin ratios, and incidence of diffuse hepatocyte hypertrophy compared to WT F344 and Sprague-Dawley (SD) rats. DEN-treated gpt delta rats showed equivalent increases in the number and area of precancerous GST-P-positive foci in the liver compared to WT rats. The livers of DEN-treated gpt delta rats also showed increased frequencies of gpt and Spi(-) mutations; such changes were not observed in DEHP-treated gpt delta rats. These results indicated that gpt delta rats (both F344 and SD backgrounds) showed comparable DEHP-induced toxicity and DEN-induced genotoxicity to those observed in WT rats. With regard to the administration period, the general toxicity of 1.2% DEHP was evident throughout the experimental period, and the genotoxicity of 10 p.p.m. DEN could be detected after 2 weeks of administration and further increased at 4 weeks. These results suggested that combined assays using gpt delta rats could detect both general toxicity and genotoxicity by the canonical 4-week administration protocol. Therefore, this assay using gpt delta rats would be applicable for risk assessment including early detection of genotoxic carcinogens and ultimately serve to reduce cancer risks in humans from environmental chemicals.
AuthorsJun-Ichi Akagi, Takeshi Toyoda, Young-Man Cho, Yasuko Mizuta, Takehiko Nohmi, Akiyoshi Nishikawa, Kumiko Ogawa
JournalCancer science (Cancer Sci) Vol. 106 Issue 5 Pg. 529-41 (May 2015) ISSN: 1349-7006 [Electronic] England
PMID25683344 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Validation Study)
Copyright© 2015 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association.
Chemical References
  • Carcinogens
  • Diethylnitrosamine
  • Diethylhexyl Phthalate
Topics
  • Animals
  • Carcinogens (administration & dosage, toxicity)
  • Diethylhexyl Phthalate (administration & dosage, toxicity)
  • Diethylnitrosamine (administration & dosage, toxicity)
  • Dose-Response Relationship, Drug
  • Liver (drug effects, pathology)
  • Male
  • Mutagenicity Tests (methods)
  • Mutation
  • Organ Size (drug effects)
  • Rats, Inbred F344
  • Rats, Sprague-Dawley
  • Rats, Transgenic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: